课题基金 / 基金详情

MONOCLONAL ANTIBODIES TO EWING'S SACOMA

MONOCLONAL ANTIBODIES TO EWING'S SACOMA
尤因氏肉瘤单克隆抗体
批准号:
3939351
负责人:
T J TRICHE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

T J TRICHE的其他基金

相似基金

相关文献

中文摘要
翻译
这是一个新项目,刚刚开始。 广泛研究 尤文氏肉瘤和相关的儿童圆形细胞肿瘤, 他们中的大多数人,都是以自己为基础, 与一种或多种抗体呈阳性反应。 无抗体 对尤文氏肉瘤有特异性,或仅限于少数肿瘤 包括尤因的,已经被确认了 它的目的是 本研究旨在生产一系列单克隆抗体, 针对选定的、特征明确的尤文肉瘤细胞系, 建立在这个实验室里。 他们将被研究, 与其他单克隆抗体相比, 此前报道。 任何发现具有强烈反应性的抗体 与尤文肉瘤细胞将进一步表征, 最终意图是将其用作潜在的诊断, 成像和治疗工具。
英文摘要
This is a new project, just commencing. Extensive studies of Ewing's sarcoma and related round cell tumors of childhood have served to distinguish most from one another on the basis of positive reactivity with one or more antibodies. No antibody specific for Ewing's sarcoma, or restricted to a few tumors including Ewing's, has been identified to date. It is the aim of the present study to produce a battery of monoclonal antibodies against selected, well-characterized Ewing's sarcoma lines established in this laboratory. They will then be studied and compared in their reactivity with other monoclonal antibodies previously reported. Any antibody found to be strongly reactive with Ewing's sarcoma cells will be further characterized, with the eventual intention to use same as a potential diagnostic, imaging, and therapeutic tool.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EWING'S SARCOMA--DIFFERENTIATION IN VITRO
A NEW HIGH MOLECULAR WEIGHT EXTRACELLULAR MATRIX PROTEIN
EWING'S SARCOMA--DIFFERENTIATION IN VITRO
EXTRACELLULAR MATRIX SYNTHESIS BY HUMAN TUMORS IN VITRO
海外基金